---
title: "Microbix Biosystems Secures CAP Order for Quality Assessment Products"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/275453525.md"
datetime: "2026-02-10T12:02:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275453525.md)
  - [en](https://longbridge.com/en/news/275453525.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275453525.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/275453525.md) | [English](https://longbridge.com/en/news/275453525.md)


# Microbix Biosystems Secures CAP Order for Quality Assessment Products

Microbix Biosystems Inc. has announced that it has begun supplying its quality assessment products (QAPs) to the College of American Pathologists (CAP) for use in CAP’s clinical laboratory proficiency-testing (PT) and external quality assessment (EQA) programs. The company confirmed that multiple QAP product SKUs have been provided to CAP and are being used at clinical laboratories participating in CAP PT/EQA programs. The specific programs using Microbix QAPs remain confidential to maintain the integrity of the proficiency testing process. Microbix aims to support additional CAP PT/EQA programs and expand its offerings in the future. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbix Biosystems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1134904) on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相關股票

- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [MBX Biosciences (MBX.US)](https://longbridge.com/zh-HK/quote/MBX.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [Direxion S&P Biotech Bear 3X (LABD.US)](https://longbridge.com/zh-HK/quote/LABD.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [Rapid Micro Biosystems (RPID.US)](https://longbridge.com/zh-HK/quote/RPID.US.md)
- [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-HK/quote/XHE.US.md)
- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md)

## 相關資訊與研究

- [Top NeurAxis Insiders Make Bold Moves With Fresh Stock Buys](https://longbridge.com/zh-HK/news/281670217.md)
- [BUZZ-Tempus AI rises after study shows AI-driven alerts improve heart valve treatment](https://longbridge.com/zh-HK/news/281390073.md)
- [Telomir seeks FDA approval for Telomir-1 to treat breast cancer](https://longbridge.com/zh-HK/news/281346305.md)
- [Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update](https://longbridge.com/zh-HK/news/281525623.md)
- [Perimeter Posts Record 2025 Revenue and Wins FDA Approval for AI Breast Imaging Device](https://longbridge.com/zh-HK/news/281274047.md)